City of Hope National Medical Center /ID# 277005, Duarte
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla

În curs de recrutareFaza 2/3

Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT07155187

A Study of ASP3082 in Adults With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
UCLA Santa Monica Hematology Oncology, Santa Monica

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT05382559

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

City of Hope, Duarte
University of California, Irvine Medical Center - Hematology/Oncology, Orange
Stanford University School of Medicine, Stanford

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT07192471

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT07566156

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

City of Hope National Medical Center /ID# 280273, Duarte
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT07409246

A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT07744126

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Providence St. Johns Health Center, Santa Monica

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT05874921

Registry Study for Radiation Therapy Outcomes

California Protons Cancer Therapy Center, San Diego

În curs de recrutareStudiu observațional

Toate vârstele · Toate sexele · Actualizat 29 sept. 2026 · NCT01255748

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Los Angeles
PHN-012-001 Site, San Diego

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT07127874

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

City of Hope Comprehensive Cancer Center, Duarte

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT06884618

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Sansum Clinic, Santa Barbara

În curs de recrutareFaza 3

Vârste de la 18 la 100 · Toate sexele · Actualizat 25 sept. 2026 · NCT05920356

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

UC San Diego Medical Center - Encinitas, Encinitas
Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UCI Health - Irvine, Irvine
și încă 14

În curs de recrutareFaza 2/3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06989437

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Children's Hospital Los Angeles ( Site 4006), Los Angeles

În curs de recrutareFaza 1/2

1 Month – 17 Years · Toate sexele · Actualizat 25 sept. 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

City of Hope, Duarte

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06150157

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

CBCC Global Research - Comprehensive Blood & Cancer Center, Bakersfield
TOI Clinical Research, Cerritos
University of California, San Diego Moores Cancer Center, La Jolla
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT06901531

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 1, Duarte
Quetzal Site 7, Los Angeles
Quetzal Site 5, Stanford

În curs de recrutareFaza 3

Vârste de la 18 la 71 · Toate sexele · Actualizat 23 sept. 2026 · NCT07504458

Intratumoral N17350 in Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles
UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
Scripps Clinic Torrey Pines - La Jolla, San Diego
și încă 1

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT07339176

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

City of Hope National Medical Center /ID# 281322, Duarte
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT07365241

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

City of Hope /ID# 243157, Duarte
City Of Hope - Seacliff /ID# 263143, Huntington Beach
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT04928846

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Sutter Auburn, Auburn
Sutter Alta Bates, Berkeley
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
și încă 19

În curs de recrutareFaza 2

Vârste de 12 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT02693535

Prospective Study to Assess a Diagnostic Aid for Cancer

Southern California Research Center, Coronado
Palomar Health, Poway
South Coast Gynecologic Oncology, San Diego

În curs de recrutareStudiu observațional

Vârste de 45 ani și peste · Toate sexele · Actualizat 21 sept. 2026 · NCT07046260

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

City Of Hope, Duarte
University Of California San Diego Moores Cancer Center, La Jolla
University of California, San Francisco- California, San Francisco
și încă 2

În curs de recrutareFaza 2/3

Toate vârstele · Toate sexele · Actualizat 18 sept. 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Childrens Hospital Los Angeles ( Site 3006), Los Angeles

În curs de recrutareFaza 1/2

1 Month – 17 Years · Toate sexele · Actualizat 17 sept. 2026 · NCT06941272

Statins to Prevent Cancer Associated Blood Clots

City of Hope, Irvine

În curs de recrutareFaza 4

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07303816

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Kadima Neuropsychiatry Institute, San Diego
Providence Medical Foundation, Santa Rosa

În curs de recrutareFaza 2

Vârste de la 18 la 80 · Toate sexele · Actualizat 15 sept. 2026 · NCT07002034

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

University of California, San Francisco, San Francisco

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 15 sept. 2026 · NCT06633224

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

City of Hope Comprehensive Cancer Center, Duarte
UCLA Medical Center, Los Angeles
Stanford Cancer Institute, Stanford

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 15 sept. 2026 · NCT04996875

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

University of Southern California /ID# 272414, Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT06953960

Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

UC Davis Health, Sacramento
UC Davis Medical Center, Sacramento

În curs de recrutare

Vârste de 18 ani și peste · Toate sexele · Actualizat 11 sept. 2026 · NCT06722508

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Santa Monica
Research Site, Santa Rosa

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 11 sept. 2026 · NCT05123482

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

University of Southern California Norris Comprehensive, Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 11 sept. 2026 · NCT06634589

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

UCI Health Chao Family Comprehensive Cancer Center, Orange
Investigational Site Number: 403, Palo Alto

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Bărbați · Actualizat 10 sept. 2026 · NCT05997615

A Phase 1/1b Study of IAM1363 in HER2 Cancers

UCSD Moores Cancer Center, La Jolla
USC Norris Comprehensive Cancer Center, Los Angeles

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT06253871

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale

În curs de recrutare

Vârste de 70 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07629206

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.